New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 27, 2014
08:35 EDTIARTIntegra LifeSciences receives FDA clearance for Titanium Bone Wedges
Integra LifeSciences announced the introduction of the Integra Titanium Bone Wedges, designed for internal fixation for bone fractures or osteotomies in the foot and ankle. The system has received 510(k) clearance from the U.S. Food and Drug Administration and will be featured at the American College of Foot and Ankle Surgeons 72nd Annual Scientific Conference. The Integra Titanium Bone Wedges may be used in corrective procedures, such as Cotton osteotomies of the medial cuneiform and Evans lengthening osteotomies. The Integra Titanium Bone Wedge is available in 15 different pre-shaped anatomical sizes, to accommodate various skeletal deformities in the foot.
News For IART From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2015
06:09 EDTIARTOsiris assumed with a Hold from Buy at Brean Capital
Brean Capital analyst Jason Wittes downgraded Osiris Therapeutics (OSIR) to Hold after assuming coverage of the name. The analyst views the stock as fairly valued at current levels and sees increased competition from Integra LifeSciences' (IART) entry into the diabetic foot ulcer market.
September 30, 2015
11:48 EDTIARTFTC requires divestitures as condition of Wright Medical, Tornier merger
Wright Medical Group (WMGI) and Tornier (TRNX) have agreed to sell Tornier's U.S. rights and assets related to its total ankle replacements and total silastic toe joint replacements to resolve Federal Trade Commission charges that the proposed $3.3B merger would illegally reduce competition for these devices, the FTC announced. Under the proposed settlement, Wright and Tornier will divest the rights and assets to these devices to Integra Lifesciences (IART) and provide Integra with intellectual property, manufacturing technology, and existing inventory, as well as other assets and assistance to ensure that Integra can effectively compete in the markets. The proposed order also requires Wright and Tornier to supply Integra with total ankle replacements for up to three years and total silastic toe joint replacements for up to a year, while Integra transitions to become an independent competitor in these markets.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use